InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,033.32
(
0.30%
)
US TECH 100
16,975.60
(
0.68%
)
Dow Jones
38,037.63
(
0.35%
)
Brent Oil
83.54
(
-0.01%
)
Bitcoin
59,349.06
(
1.89%
)

Replies to post #528 on Eagle Pharmaceuticals, inc. (EGRX)

Replies to #528 on Eagle Pharmaceuticals, inc. (EGRX)

DewDiligence

10/14/16 11:47 AM

#529 RE: Bickema #528

LLY will undoubtedly sue under Hatch-Waxman in order to trigger the 30-month stay (just as TEVA did when EGRX submitted the Bendeka Paragraph-IV challenge). That won't rule out a patent settlement, of course.